Sharifa Fazili, MD
Obstetrics & Gynecology · Clarence, NYNPI 1164577516
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $405 of the $515 with a category attached, or 78.6%. 7 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 49.5% of the total. Reporting peaked in 2023 at $125 and has fallen 59.4% since, to $51 in 2025.
Across 29 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$255
- AMAG Pharmaceuticals, Inc.$110
- Coopersurgical, Inc.$48
- AbbVie$40
- Astellas Pharma US Inc$26
- Hologic Sales And Service, LLC$23
- plus $12 from 1 others
Across 97 payments — averaging $4427.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astellas Pharma Global Development$199K
- GRT US Holding, Inc.$147K
- AbbVie$53K
- Mylan Inc.$12K
- Mylan Technologies Inc.$12K
- Myovant Sciences Inc.$7K
What the payments were for
- Food & beverage$40579%
- Education$11021%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 12 | $255 |
| AMAG Pharmaceuticals, Inc. | 10 | $110 |
| Coopersurgical, Inc. | 2 | $48 |
| AbbVie | 2 | $40 |
| Astellas Pharma US Inc | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Amgen | 1 | $12 |
How this compares
$515 in reported general payments places this provider in the 60th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alendronate Sodium | 20 | $225 |
| Fluconazole | 17 | $53 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Clarence
- Mary PolanNew York$862K
- Steven GoldsteinNew York$551K
- Veronica LernerNew York$368K
- Lisa EngNew York$219K
- Theodore GoldmanEast Northport$213K
- Miriam CremerBrooklyn$196K
- Rachel MaschNew York$187K
- Amy PollackNew York$184K
- Jian Qun HuangNew York$160K
- Carolyn WesthoffNew York$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.